What is known and objective Acinetobacter baumannii is one of the most important
nosocomial pathogens with the ability to cause infections such as meningitis, pneumonia …

Acinetobacter baumannii is one of the most common multidrug-resistant pathogens causing
nosocomial infections. The prevalence of multidrug-resistant A. baumannii infections is …

Acinetobacter baumannii is widely distributed in nature and in hospital settings and is a
common pathogen causing various infectious diseases. Currently, the drug resistance rate …

Acinetobacter baumannii is a pathogen of increasing concern, commonly causing outbreaks
in the hospital environment. Of particular concern, A. baumannii strains exhibiting resistance …

Tigecycline is regarded as a last-resort treatment for multidrug-resistant Acinetobacter
baumannii. However, tigecycline resistance in A. baumannii has increased worldwide. In …

Acinetobacter baumannii is an important pathogen in hospital acquired infections. Although
tigecycline currently remains a potent antibiotic for treating infections caused by multidrug …

The mechanism of tigecycline resistance in A. baumannii remains largely unclear. In this
study, we selected a tigecycline-resistant and a tigecycline-susceptible strain from a …

Objective Acinetobacter baumannii has emerged as a problematic hospital pathogen and
tigecycline is among the few remaining antibiotics retaining activity against multidrug …

Because of its remarkable ability to acquire antibiotic resistance and to survive in
nosocomial environments, Acinetobacter baumannii has become a significant nosocomial …

Acinetobacter spp. are non-fermentative, strictly aerobic, Gram-negative microorganisms
with a confusing taxonomic history. The Acinetobacter baumannii–Acinetobacter …